Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
about
RNA Nanotherapeutics for the Amelioration of Astroglial Reactivity.Dynamics of neutrophil gelatinase-associated lipocalin plasma and cerebrospinal fluid concentrations in older males.Achievements and obstacles of remyelinating therapies in multiple sclerosis.Role of the Fractalkine Receptor in CNS Autoimmune Inflammation: New Approach Utilizing a Mouse Model Expressing the Human CX3CR1 Variant
P2860
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
@ast
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
@en
type
label
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
@ast
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
@en
prefLabel
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
@ast
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
@en
P2093
P2860
P50
P1476
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
@en
P2093
Ann M Dring
Fredrik Piehl
Jeppe Romme Christensen
Joakim Bergman
Shahin Aeinehband
Tomas Olsson
Tommy Bergenheim
P2860
P356
10.1212/NXI.0000000000000191
P50
P577
2016-01-07T00:00:00Z